Purchase Order 75N92024P00373
Award Date
9/25/24
Potential Completion Date
9/24/25
Potential Value
$52K
Funding Federal Agency
National Human Genome Research Institute
Contracting Federal Agency
National Heart Lung and Blood Institute
Awardee
Cell Signaling Technology, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Danvers, MA 01923, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $95,200 firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Cell Signaling Technology, Inc. (CST) for proteomic characterization of FBXW7-mutant CRISPR-edited uterine cancer cells. The contract has no set-aside designation and was awarded on January 24, 2019 with a completion date of April 23, 2020. CST is a private, family-owned company that provides specialized...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Human Genome Research Institute awarded a firm fixed-price purchase order to Cell Signaling Technology, Inc. (CST), a private, for-profit manufacturing company, to provide proteomic characterization of FBXW7-mutant CRISPR-edited uterine cancer cells. The award, valued at $148,500.00, did not have a set-aside designation and was completed on August 15, 2020. CST has previously provided proteome...
This is a $3,800 fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Cell Signaling Technology, Inc. (CST). The contract is for TAS service work order. CST is a private, for-profit company that specializes in developing and producing antibodies, kits, and reagents for applied systems biology research related to cancer. CST has previously provided proteomic analysis, mass...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Department of Health and Human Services (HHS) to Cell Signaling Technology, Inc. (CST), a private, family-owned company that develops and produces antibodies, kits, and reagents for cell signaling research. The $150,000.00 firm fixed price contract is for the detection of oncogenic targets using a multiplex bead enzyme-linked immunosorbent assay (ELISA). The contract has a total small business set aside...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $102,000.00 firm fixed price purchase order to Cell Signaling Technology, Inc. to provide PTMScan Ubiquitin Standard Service. This contract has no set-aside designation. Cell Signaling Technology is a private, family-owned company that develops and produces antibodies, kits, and reagents used to study cell signaling pathways, with a focus on applied systems biology...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Cell Signaling Technology, Inc., a private company based in Danvers, Massachusetts. The contract, valued at $24,000.00, is for the provision of specialized "PhosphoScan" research services. The contract has a period of performance from September 10, 2014, to September 30, 2015, and was not set aside for any particular type of business. Cell Signaling Technology, Inc. is a for-profit...
This is a $22,755 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services based in South San Francisco, California. The contract is for the provision of Mission Bio's Tapestri Single-Cell DNA and Protein Reagent Kits, sequencing instruments, and genomic analysis services to support critical biomedical research efforts in areas such as infectious...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, to Cell Signaling Technology, Inc., a private, for-profit manufacturer of research products. The $13,220.05 firm fixed-price purchase order is for the provision of antibodies and reagents for Western blot analysis, designated as AMBIS 2261414 - CELL TECHNOLOGIES. The award does not have a set-aside designation, indicating Cell Signaling...
This is a $93,300.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Cisbio US, Inc., a foreign-owned for-profit company, for the provision of 10,000 HISTONE2 HTRF Assay test kits. The award was not set aside. Cisbio US, Inc. has previously provided assay kits, cell lines, and collagen reagents related to disease research to various Department of Health and Human Services (HHS) agencies, including the NIH, Centers for Disease Control and...
This is a $22,755 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services based in South San Francisco, California. The contract is for the provision of Mission Bio's Tapestri Single-Cell DNA and Protein Reagent Kits, sequencing instruments, and genomic analysis services to support critical biomedical research efforts in areas such as infectious disease,...